Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging.

Neurofibromatosis type 1 (NF1) is a neurocutaneous syndrome characterized by the development of multiple peripheral nerve sheath tumors, the majority of which are benign neurofibromas. However, malignant peripheral nerve sheath tumors (MPNSTs) occur with a 10 % lifetime risk in patients with NF1, of...

Descripción completa

Detalles Bibliográficos
Publicado en:Skeletal Radiology Vol. 42; no. 9; pp. 1317 - 1323
Autores principales: Ahlawat, Shivani, Blakeley, Jaishri, Montgomery, Elizabeth, Subramaniam, Rathan M, Belzberg, Allan, Fayad, Laura M
Formato: case study research Journal Article
Publicado: Springer Nature Sep2013
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104083760&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104083760
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        03642348
        O14
      jtl: Skeletal Radiology
      issn: 03642348
      maglogo: N
    pubinfo:
      dt: Sep2013
      vid: 42
      iid: 9
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        104083760
        NLM23649401
        2012200183
        10.1007/s00256-013-1626-3
        NLM23649401
        PMC3991125
        104083760
      ppf: 1317
      ppct: 6
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging.
      aug:
        au:
          Ahlawat, Shivani
          Blakeley, Jaishri
          Montgomery, Elizabeth
          Subramaniam, Rathan M
          Belzberg, Allan
          Fayad, Laura M
        affil: The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 North Wolfe Street, Baltimore, MD, 21287, USA, sahlawa1@jhmi.edu.
      sug:
        subj:
          Diagnostic Errors Prevention and Control
          Fludeoxyglucose F 18 Diagnostic Use
          Magnetic Resonance Imaging Methods
          Neoplasms, Multiple Primary Diagnosis
          Neurofibromatosis 1 Diagnosis
          Tomography, Emission-Computed Methods
          Soft Tissue Neoplasms Diagnosis
          Diagnosis, Differential
          Fludeoxyglucose F 18 Pharmacokinetics
          Human
          Male
          Middle Age
          Neoplasms, Multiple Primary Metabolism
          Neurofibromatosis 1 Metabolism
          Radiopharmaceuticals Diagnostic Use
          Radiopharmaceuticals Pharmacokinetics
          Reproducibility of Results
          Sensitivity and Specificity
          Soft Tissue Neoplasms Metabolism
          Middle Aged: 45-64 years
          Male
      ab: Neurofibromatosis type 1 (NF1) is a neurocutaneous syndrome characterized by the development of multiple peripheral nerve sheath tumors, the majority of which are benign neurofibromas. However, malignant peripheral nerve sheath tumors (MPNSTs) occur with a 10 % lifetime risk in patients with NF1, often developing within a neurofibroma. When clinical suspicion for an MPNST arises, imaging with FDG PET and MRI is performed to characterize a peripheral tumor for potential malignancy. In this report, we describe a patient with NF-1 who had two peripheral tumors with similar features by PET, both suspicious for MPNST, but differing features by MRI, one of which was subsequently determined to be an MPNST and the second to be a schwannoma.
      pubtype: Academic Journal
      doctype:
        case study
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N